0000950142-19-000022.txt : 20190104 0000950142-19-000022.hdr.sgml : 20190104 20190104165407 ACCESSION NUMBER: 0000950142-19-000022 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190104 DATE AS OF CHANGE: 20190104 EFFECTIVENESS DATE: 20190104 FILER: COMPANY DATA: COMPANY CONFORMED NAME: vTv Therapeutics Inc. CENTRAL INDEX KEY: 0001641489 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473916571 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-329735 FILM NUMBER: 19510804 BUSINESS ADDRESS: STREET 1: 4170 MENDENHALL OAKS PKWY CITY: HIGH POINT STATE: NC ZIP: 27265 BUSINESS PHONE: 336-841-0300 MAIL ADDRESS: STREET 1: 4170 MENDENHALL OAKS PKWY CITY: HIGH POINT STATE: NC ZIP: 27265 FORMER COMPANY: FORMER CONFORMED NAME: VTV Therapeutics Inc. DATE OF NAME CHANGE: 20150506 D 1 primary_doc.xml X0708 D LIVE 0001641489 vTv Therapeutics Inc. 4170 MENDENHALL OAKS PKWY HIGH POINT NC NORTH CAROLINA 27265 336-841-0300 DELAWARE None VTV Therapeutics Inc. Corporation true 2015 Stephen Holcombe 4170 Mendenhall Oaks Pkwy High Point NC NORTH CAROLINA 27265 Executive Officer Rudy Howard 4170 Mendenhall Oaks Pkwy High Point NC NORTH CAROLINA 27265 Executive Officer Jeffrey Kindler 4170 Mendenhall Oaks Pkwy High Point NC NORTH CAROLINA 27265 Executive Officer Director Steven Cohen 4170 Mendenhall Oaks Pkwy High Point NC NORTH CAROLINA 27265 Director John Fry 4170 Mendenhall Oaks Pkwy High Point NC NORTH CAROLINA 27265 Director Craig Parker 4170 Mendenhall Oaks Pkwy High Point NC NORTH CAROLINA 27265 Director Paul Savas 4170 Mendenhall Oaks Pkwy High Point NC NORTH CAROLINA 27265 Director Noel Spiegel 4170 Mendenhall Oaks Pkwy High Point NC NORTH CAROLINA 27265 Director Howard Weiner 4170 Mendenhall Oaks Pkwy High Point NC NORTH CAROLINA 27265 Director Pharmaceuticals Decline to Disclose 06b false 2018-12-27 false true true false 0 10000000 1500000 8500000 See the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on December 11, 2018. false 0 0 0 0 false vTv Therapeutics Inc. /s/ Rudy C. Howard Rudy C. Howard Chief Financial Officer 2019-01-04